SCF ENCYCLOPEDIA ENTRY

REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME (POSTPARTUM)

SCF-RDOS Registry Code: SCF-RDOS-PPD-NEURO-006

Disease Type Classification: Postpartum Neurological Disorder → Cerebral Vascular Tone Dysregulation Syndrome → Reversible Cerebral Vasoconstriction Syndrome (RCVS)

SCF Classification Status: Maternal Cerebral Vascular Regulatory Failure Syndrome

SCF Severity Classification: Acute Neurovascular Autoregulatory Dysfunction Disorder

Adaptive Module Activation

• Universal Core Module
• Neurobiology Expansion
• Cerebrovascular Biology Expansion
• Endothelial Biology Expansion
• Hemodynamic Biology Expansion
• Neurovascular Coupling Expansion
• Connectomics Expansion
• Mitochondrial Biology Expansion
• Critical Care Expansion
• Maternal Survival Biology Expansion
• Autonomic Biology Expansion
• SCF Pathophysiology Protocol (Extended Version)
• SCF Universal Cross-System Analysis Module

1. SCOPE & POSITIONING

Definition

Reversible Cerebral Vasoconstriction Syndrome (RCVS) is an acute neurovascular disorder characterized by transient multifocal narrowing of cerebral arteries resulting in severe thunderclap headaches, cerebral hypoperfusion, vascular instability, ischemic injury, hemorrhage, seizures, and neurological dysfunction.

The postpartum period represents one of the most recognized biological settings for RCVS due to rapid hormonal withdrawal, endothelial instability, autonomic dysregulation, cerebral vascular hyperreactivity, and postpartum hemodynamic remodeling.

Within the SCF framework, RCVS is classified as:

A cerebral vascular autoregulatory intelligence failure syndrome characterized by transient dysregulation of arterial tone, impaired neurovascular coupling, disrupted cerebral perfusion homeostasis, and reversible collapse of adaptive cerebrovascular control systems.

2. SCOPE & CLINICAL POSITIONING

SCF Hierarchical Placement

Normal Cerebral Autoregulation

↓

Pregnancy Vascular Adaptation

↓

Postpartum Hormonal Withdrawal

↓

Neurovascular Instability

↓

Cerebral Arterial Hyperreactivity

↓

Reversible Cerebral Vasoconstriction Syndrome

↓

Neurologic Dysfunction

↓

Recovery or Secondary Cerebrovascular Injury

Major Postpartum Associations

Hypertensive Disorders

• Postpartum Preeclampsia
• Postpartum Eclampsia
• HELLP Syndrome
• Postpartum Hypertensive Crisis

Neurovascular Disorders

• Posterior Reversible Encephalopathy Syndrome (PRES)
• Cerebral Venous Sinus Thrombosis
• Postpartum Stroke
• Subarachnoid Hemorrhage

Autonomic Disorders

• Sympathetic Hyperactivation
• Catecholamine Surge Syndromes

Medication-Associated Triggers

• Vasoconstrictive agents
• Ergot derivatives
• Certain antidepressants
• Sympathomimetic medications

3. ETIOPATHOGENIC CORE

Central SCF Principle

RCVS develops when cerebral arterial tone regulation becomes unstable, resulting in inappropriate vasoconstriction of medium and large cerebral arteries, producing fluctuating cerebral perfusion and vulnerability to ischemic and hemorrhagic complications.

The syndrome reflects failure of:

• Cerebral autoregulation
• Endothelial signaling
• Neurovascular coupling
• Vascular tone control
• Autonomic balance
• Cerebral perfusion stability

Core SCF Equation

Postpartum Neurovascular Instability

Autoregulatory Failure

Cerebral Vasoconstriction

=

Reversible Cerebral Vasoconstriction Syndrome

4. ETIOLOGY AND TRIGGER CLUSTERS

Cluster A — Postpartum Hormonal RCVS

Associated Factors:

• Rapid estrogen withdrawal
• Progesterone decline
• Endothelial adaptation failure

Primary Failure:

Neurovascular instability

Cluster B — Hypertensive RCVS

Associated Conditions:

• Preeclampsia
• Eclampsia
• Severe postpartum hypertension

Primary Failure:

Autoregulatory overload

Cluster C — Sympathetic Hyperactivation RCVS

Associated Factors:

• Catecholamine excess
• Severe pain
• Emotional stress

Primary Failure:

Excess vascular constriction signaling

Cluster D — Medication-Induced RCVS

Associated Factors:

• Ergot alkaloids
• Vasoconstrictive drugs
• Sympathomimetics

Primary Failure:

Pharmacologic vascular dysregulation

Cluster E — Multifactorial Neurovascular RCVS

Associated Factors:

• Combined endothelial dysfunction
• Hormonal instability
• Hemodynamic stress

Primary Failure:

Global autoregulatory failure

5. SCF FAULT ARCHITECTURE

Tier I — Neurovascular Trigger Activation

Events:

• Hormonal withdrawal
• Hypertension
• Sympathetic activation

Result:

Vascular hyperreactivity

Tier II — Autoregulatory Dysfunction

Features:

• Endothelial signaling imbalance
• Loss of vascular tone stability

Result:

Arterial dysregulation

Tier III — Cerebral Vasoconstriction

Features:

• Multifocal arterial narrowing
• Perfusion variability

Result:

Regional hypoperfusion

Tier IV — Clinical RCVS

Features:

• Thunderclap headaches
• Neurologic symptoms
• Seizures

Result:

Established syndrome

Tier V — Secondary Neurovascular Injury

Features:

• Ischemic stroke
• PRES
• Subarachnoid hemorrhage
• Intracerebral hemorrhage

Result:

Complicated disease

Tier VI — Neurocritical Failure

Features:

• Severe cerebral injury
• Persistent neurologic deficits

Result:

Maternal survival threat

6. MOLECULAR MULTI-OMICS PATHOGENESIS MAP

Genomics

Affected Pathways:

• Vascular reactivity regulation
• Endothelial resilience pathways
• Oxidative stress control
• Neurovascular signaling

Transcriptomics

Activation of:

• Vasoconstrictive signaling pathways
• Inflammatory cascades
• Stress-response genes

Proteomics

Elevated Biomarkers:

• Endothelin-1
• IL-6
• TNF-α
• VEGF dysregulation markers

Metabolomics

Features:

• Cerebral energy instability
• Oxidative stress burden
• Regional hypoperfusion metabolism

Endotheliomics

Features:

• Endothelial dysfunction
• Nitric oxide imbalance
• Vasoregulatory disruption

Connectomics

Features:

• Dynamic neural network disruption
• Reversible connectivity abnormalities

Mitochondriomics

Features:

• Regional ATP instability
• Neurovascular bioenergetic stress

7. SCF PATHOGENESIS FLOW

Postpartum Physiologic Transition

↓

Hormonal Withdrawal

↓

Endothelial Instability

↓

Autonomic Dysregulation

↓

Cerebral Arterial Hyperreactivity

↓

Multifocal Vasoconstriction

↓

Perfusion Instability

↓

Thunderclap Headaches

↓

RCVS

↓

Recovery

or

↓

Stroke / PRES / Hemorrhage

8. SCF FUNCTIONAL MATRIX

9. SCF TRINITY FRAMEWORK

Structural Integrity Failure

Affected Structures:

• Medium cerebral arteries
• Large cerebral arteries
• Neurovascular units
• Endothelial interfaces

Primary Failure:

Loss of vascular tone integrity

Energetic Integrity Failure

Affected Systems:

• Cerebral oxygen delivery
• Neurovascular metabolic coupling
• Mitochondrial energy generation

Primary Failure:

Regional cerebral energy instability

Informational Integrity Failure

Affected Systems:

• Neurovascular communication
• Autoregulatory signaling
• Cerebral perfusion intelligence networks

Primary Failure:

Loss of adaptive vascular regulation

10. CLINICAL PHENOTYPES

Phenotype A — Headache-Dominant RCVS

Characteristics:

• Recurrent thunderclap headaches
• Minimal neurologic deficits

Phenotype B — PRES-Associated RCVS

Characteristics:

• Visual symptoms
• Seizures
• Cerebral edema

Phenotype C — Ischemic RCVS

Characteristics:

• Focal neurologic deficits
• Cerebral infarction

Phenotype D — Hemorrhagic RCVS

Characteristics:

• Cortical subarachnoid hemorrhage
• Intracerebral hemorrhage

Phenotype E — Fulminant Neurocritical RCVS

Characteristics:

• Multifocal vascular involvement
• Severe neurologic decline

11. SCF PATHOPHYSIOLOGY PROTOCOL — EXTENDED VERSION

Etiopathogenic Core

Failure of cerebral arterial tone regulation resulting in reversible but potentially dangerous cerebral vasoconstriction and perfusion instability.

SCF Fault Domains

1. Hormonal withdrawal
2. Endothelial dysfunction
3. Autoregulatory failure
4. Vasoconstriction
5. Perfusion instability
6. Secondary neurovascular injury
7. Neurologic dysfunction

Trigger → Symptomatology → Fault Mapping

12. SCF THERAPEUTIC MECHANISMS (PCR BRAID)

PREVENTATIVE

Objectives

Prevent neurovascular dysregulation.

Targets:

• Blood pressure control
• Endothelial stability
• Early recognition of warning symptoms

CURATIVE

Objectives

Restore cerebral vascular homeostasis.

Targets:

• Vasoconstriction
• Perfusion instability
• Neurovascular dysfunction

Clinical Interventions:

• Neurocritical monitoring
• Blood pressure optimization
• Removal of triggering agents
• Symptom-directed therapy
• Seizure management when indicated

RESTORATIVE

Objectives

Restore normal neurovascular intelligence networks.

Targets:

• Endothelial recovery
• Cerebral autoregulation
• Neurovascular coupling
• Functional neurologic recovery

Potential SCF Strategies:

• Endothelial restoration platforms
• Neurovascular resilience therapeutics
• Mitochondrial neuroprotection systems
• Precision neurorehabilitation programs

13. CURRENT STANDARD OF CARE

Diagnostic Evaluation

Common Symptoms

• Thunderclap headache
• Recurrent severe headaches
• Visual disturbances
• Seizures
• Weakness
• Speech abnormalities
• Altered mental status

Neuroimaging

Preferred Studies:

• CT angiography
• MR angiography
• MRI brain

Typical Finding:

• Multifocal segmental cerebral arterial narrowing (“string-of-beads” appearance)

Follow-Up Imaging

Demonstration of reversibility within weeks to months is part of diagnostic confirmation.

Treatment

Acute Management

• Removal of provoking factors
• Blood pressure management
• Seizure treatment when needed
• Neurocritical observation

Monitoring

• Serial vascular imaging
• Neurologic surveillance
• Evaluation for stroke and hemorrhage

14. TRANSLATIONAL BLUEPRINT

Diagnostic Biomarkers

Endothelial Dysfunction

• Endothelin-1
• Nitric oxide pathway markers
• vWF

Neurovascular Injury

• GFAP
• S100B
• NSE

Inflammation

• IL-6
• TNF-α
• CRP

Cerebral Perfusion

• Advanced neuroimaging biomarkers

Clinical Endpoints

Primary

• Reversal of vasoconstriction

Secondary

• Prevention of stroke
• Neurologic recovery
• Functional independence
• Maternal survival

15. PROJECT RHENOVA — INTEGRATION PATHWAYS

RHENOVA-A

Neurovascular Stabilization

RHENOVA-B

Endothelial Recovery

RHENOVA-C

Autoregulatory Restoration

RHENOVA-D

Perfusion Optimization

RHENOVA-E

Neural Network Recovery

RHENOVA-F

Functional Reintegration

16. NEXT STRATEGIC RESEARCH PATHWAYS

Priority 1

Postpartum neurovascular biomarker panels

Priority 2

Endothelial resilience therapeutics

Priority 3

RCVS-PRES interaction mapping

Priority 4

AI-assisted autoregulatory failure prediction

Priority 5

Neurovascular bioenergetic restoration platforms

Priority 6

Precision postpartum cerebrovascular rehabilitation

17. SCF DBI INTERPRETATION

Decentralized Biological Intelligence Failure

Cellular Layer

Endothelial and neural cells experience transient dysregulation of perfusion and metabolic support.

Tissue Layer

Neurovascular units lose coordinated control of cerebral blood flow.

Organ Layer

The brain develops unstable regional perfusion with vulnerability to ischemic and hemorrhagic injury.

System Layer

Vascular, neurologic, autonomic, endocrine, and immune systems become temporarily desynchronized.

Whole-Organism Layer

The maternal organism experiences failure of cerebral vascular intelligence networks responsible for maintaining stable blood flow to critical brain regions, producing severe headaches and potentially life-threatening neurological complications.

18. SCF LAYMAN’S SUMMARY

Reversible Cerebral Vasoconstriction Syndrome is a condition in which blood vessels in the brain suddenly narrow and spasm, causing extremely severe headaches and sometimes stroke-like symptoms.

In the postpartum period, rapid hormonal changes, blood pressure problems, and vascular stress can trigger this condition.

The hallmark symptom is a sudden thunderclap headache that reaches maximum intensity within seconds to minutes.

Most patients recover completely when the condition is recognized and managed appropriately, but some develop serious complications such as:

• Stroke
• Brain hemorrhage
• Seizures
• PRES
• Persistent neurological deficits

Because RCVS can mimic other life-threatening neurological emergencies, urgent medical evaluation is essential.

SCF-RDOS INDICATION SUMMARY

INDEX

SCF Master Registry Classification

• SCF-RDOS-PPD-NEURO-001 — Postpartum Stroke
• SCF-RDOS-PPD-NEURO-002 — Postpartum Posterior Reversible Encephalopathy Syndrome (PRES)
• SCF-RDOS-PPD-NEURO-003 — Intracerebral Hemorrhage (ICH)
• SCF-RDOS-PPD-NEURO-004 — Subarachnoid Hemorrhage (SAH)
• SCF-RDOS-PPD-NEURO-005 — Cerebral Venous Sinus Thrombosis (CVST)
• SCF-RDOS-PPD-NEURO-006 — Reversible Cerebral Vasoconstriction Syndrome (RCVS)

Domain Pathway

Postpartum Disorders → Neurologic Disorders → Cerebrovascular Regulatory Disorders → Reversible Cerebral Vasoconstriction Syndrome

Adaptive Modules Applied

Universal Core Module + Neurobiology Expansion + Cerebrovascular Biology Expansion + Endothelial Biology Expansion + Hemodynamic Biology Expansion + Neurovascular Coupling Expansion + Autonomic Biology Expansion + Connectomics Expansion + Critical Care Expansion

SCF Encyclopedia Series

Maternal Postpartum Disorders Encyclopedia (Neurovascular Regulation, Cerebral Autoregulation, Stroke Prevention, Neurocritical Care & Maternal Survival Biology Volume) — Version 1.0.0